We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTU
5351
PUT
DELISTED
Altitude Acquisition Corp
ALTU
$2.1M ﹤0.01%
211,600
+83,900
+66% +$836K
DPST icon
5352
PUT
Direxion Daily Regional Banks Bull 3X ETF
DPST
$398M
$2.09M ﹤0.01%
8,690
-3,990
-31% -$1.23M
ALGM icon
5353
Allegro MicroSystems
ALGM
$8.63B
$2.09M ﹤0.01%
+100,990
New +$2.41M
BRKR icon
5354
PUT
Bruker
BRKR
$8.81B
$2.09M ﹤0.01%
33,300
+1,000
+3% +$61.3K
OPRX icon
5355
CALL
OptimizeRx
OPRX
$159M
$2.09M ﹤0.01%
76,300
+28,100
+58% +$833K
VERV
5356
CALL
DELISTED
Verve Therapeutics
VERV
$2.09M ﹤0.01%
136,800
+127,900
+1,437% +$1.98M
CIM
5357
PUT
Chimera Investment
CIM
$987M
$2.09M ﹤0.01%
78,900
+26,000
+49% +$771K
QABA icon
5358
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$94.6M
$2.09M ﹤0.01%
42,005
+11,125
+36% +$580K
JMIA
5359
PUT
Jumia Technologies
JMIA
$784M
$2.09M ﹤0.01%
344,400
-119,900
-26% -$877K
KRTX
5360
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.09M ﹤0.01%
16,500
+5,200
+46% +$598K
NXRT
5361
NexPoint Residential Trust
NXRT
$617M
$2.08M ﹤0.01%
33,351
-73,874
-69% -$5.62M
ATHM icon
5362
PUT
Autohome
ATHM
$2.61B
$2.08M ﹤0.01%
53,000
+7,000
+15% +$218K
CFR icon
5363
CALL
Cullen/Frost Bankers
CFR
$10.5B
$2.08M ﹤0.01%
17,900
+100
+0.6% +$12.8K
NUS icon
5364
CALL
Nu Skin
NUS
$229M
$2.08M ﹤0.01%
48,100
+23,200
+93% +$1.06M
TEL icon
5365
PUT
TE Connectivity
TEL
$63B
$2.08M ﹤0.01%
18,400
+4,700
+34% +$582K
LKFT
5366
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$2.08M ﹤0.01%
37,300
+16,700
+81% +$990K
STOR
5367
PUT
DELISTED
STORE Capital Corporation
STOR
$2.08M ﹤0.01%
79,800
-22,400
-22% -$620K
URTY icon
5368
ProShares UltraPro Russell2000
URTY
$360M
$2.08M ﹤0.01%
53,142
+13,514
+34% +$720K
ALT icon
5369
CALL
Altimmune
ALT
$584M
$2.08M ﹤0.01%
177,600
+57,500
+48% +$355K
JNUG icon
5370
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$562M
$2.08M ﹤0.01%
62,100
+2,800
+5% +$164K
SHLX
5371
DELISTED
Shell Midstream Partners, L.P.
SHLX
$2.08M ﹤0.01%
147,721
-42,964
-23% -$606K
ETAC
5372
PUT
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$2.08M ﹤0.01%
207,800
-183,100
-47% -$1.82M
PPH icon
5373
CALL
VanEck Pharmaceutical ETF
PPH
$977M
$2.08M ﹤0.01%
+27,000
New +$2.11M
LRN icon
5374
Stride
LRN
$3.48B
$2.07M ﹤0.01%
50,802
-161,549
-76% -$5.98M
ONTO icon
5375
CALL
Onto Innovation
ONTO
$21.2B
$2.07M ﹤0.01%
29,700
-19,400
-40% -$1.44M

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.